Lilly Is Revved Up About Alzheimer's Opportunity

 
• By Jessica Merrill

The upcoming filing of Lilly's Alzheimer's antibody donanemab dominated the company's second quarter call. Lilly is also developing a new blood test to confirm diagnosis and a second-generation antibody. 

race car
Lilly is getting ready to file a new Alzheimer's drug for accelerated approval • Source: Alamy

More from Earnings

More from Business